Virax Biolabs Group (VRAX) Stock Chart
NASDAQ: VRAXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
VRAX technical summary
The 14-day Relative Strength Index (RSI) is 12.2, below 30, the level many traders consider oversold. Over the past year, the stock ranged from $0.2928 (Nov 19, 2026) to $2.18 (Oct 7, 2026); the current price sits 2% of the way from the low to the high. Annualized 30-day volatility is 160.8%.
Based on the last session's high, low and close, the classic pivot point is $0.3434, with first resistance at $0.3581 and first support at $0.3172. These indicators describe past price behavior for Virax Biolabs Group; they are not predictions.
Summary generated from market data by MetaCap's automated system. Methodology
Technical indicators
- RSI (14)
- 12.2
- Volatility (30d, ann.)
- 160.8%
- Beta
- —
- 1Y high
- 2.18 (Oct 7)
- 1Y low
- 0.2928 (Nov 19)
- Last close
- 0.3319
VRAX price performance
1 week
-45.82%
1 month
-75.23%
VRAX price return, excluding dividends.
Moving averages
| Period | Simple (SMA) | Exponential (EMA) |
|---|---|---|
| 5-day | 0.4072Price below | 0.4238Price below |
| 10-day | 0.5297Price below | 0.5545Price below |
| 20-day | 0.837Price below | 0.8086Price below |
Moving averages are computed from daily closing prices over the past year. What is a moving average?
Pivot points
| Level | Price |
|---|---|
| Resistance 3 (R3) | 0.399 |
| Resistance 2 (R2) | 0.3843 |
| Resistance 1 (R1) | 0.3581 |
| Pivot point | 0.3434 |
| Support 1 (S1) | 0.3172 |
| Support 2 (S2) | 0.3025 |
| Support 3 (S3) | 0.2763 |
Classic floor-trader pivots from the last session's high, low and close. How pivot points work